We are pleased to announce that synbrAIn has extended its ISO 9001 Certification for the “Quality Management System” to its offices in Palermo and Verona. ISO 9001 is an internationally...

synbrAIn has obtained ISO 13485 Certification, the standard for Quality Management of Medical Devices, placing patient safety at the center. This certification aims to standardize regulatory...

During the first day of Team Building 2024, the new Milan headquarters was officially inaugurated, and an analysis was conducted on the results achieved in 2023 along with forecasts for the current...

The joint Congress of SIRM (Italian Society of Medical and Interventional Radiology) with AIMN (Italian Association of Nuclear Medicine and Molecular Imaging) and AIRO (Italian Association of...

Palermo, 19/07/2024 – The master’s degrees in Artificial Intelligence Engineering and Cybersecurity awarded by the University of Enna Kore (UNIKORE) are the result of years of research and innovation...

Milan, 02/02/2024 – In an exclusive interview with Tracce, Roberto Pagani, founder and CEO of synbrAIn, reflects on the most significant moments that have shaped the company’s journey. A clear vision...

We are delighted to announce a new success in the field of medical imaging: Senticlab’s team has won the hackathon organized by the Regional Center of Excellence for Personalized Diagnosis and...

The continuous advancement in medicine and artificial intelligence is enriched by a series of open competitions designed to challenge data scientists, medical professionals, and researchers to develop...

n recent years, synbrAIn has achieved major recognition and funding at both national and international levels, thanks to its strong work culture and commitment to delivering high-quality and...

In an exclusive video interview with Story Time, Roberto Pagani, CEO of synbrAIn, offered insight into the world of this promising technology company. With a strong focus on the strategic use of...

In recent years, synbrAIn has made significant strides in the field of Digital Healthcare, developing numerous AI and machine learning-driven solutions to support medical diagnostics. Within this...

MIA-COV19D is an international competition organized by the University of Lincoln (UK), aimed at developing new solutions for identifying COVID-19-related diseases through the analysis of lung CT...

As we announced a few weeks ago, the launch of MS humanAId by Emme Esse has seen synbrAIn’s active involvement in developing a system that leverages artificial intelligence to support diagnostic...

The non-profit organization Cancro Primo Aiuto has acquired the MS humanAId platform, developed by EMME ESSE, a synbrAIn partner, to donate it to ASST Brianza, enabling its deployment in additional...

ImageCLEF is an international initiative organized by the CLEF initiative lab, aimed at fostering the development of new AI and machine learning-based solutions to address challenges in the healthcare...

Among the various collaborations initiated by synbrAIn, one stands out as particularly significant in the healthcare sector: its partnership with Emme Esse. Emme Esse is a company with over 40 years...

synbrAIn was born in 2019 from the merger of GetLeads and Arcaspark. Since then, the company has been experiencing constant growth in terms of personnel, know-how, and overall economic and corporate...

Lung cancer is a severe disease that leads to a high number of fatalities. Among all types of cancer, it is the leading cause of cancer-related deaths worldwide. The symptoms of lung cancer typically...

As part of its ongoing commitment to innovation, the synbrAIn team has launched AIDE-X, an acronym for Artificial Intelligence for Early Detection of Lung Diseases from Chest X-ray Images. AIDE-X is a...

In the fields of medicine and healthcare, it is not uncommon for private and public companies to invest significantly in research and new technologies. Not surprisingly, over the past decade, the...